Wealthcare Advisory Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Wealthcare Advisory Partners’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-142	Closed	-$31K	–	2106
2021 Q1	$31K	Buy	+142	New	+$26.7K	﹤0.01%	1058
2020 Q2	–	Sell	-59	Closed	-$5K	–	1508
2020 Q1	$5K	Sell	59 -19	-24%	-$2.01K	﹤0.01%	1133
2019 Q4	$8K	Buy	78 +24	+44%	+$2.69K	﹤0.01%	1019
2019 Q3	$6K	Hold	54	–	–	﹤0.01%	1053
2019 Q2	$9K	Hold	54	–	–	﹤0.01%	947
2019 Q1	$9K	Hold	54	–	–	﹤0.01%	851
2018 Q4	$5K	Buy	+54	New	+$7.08K	﹤0.01%	957

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Wealthcare Advisory Partners's GWPH Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 142 shares — an estimated $31K sold.

Wealthcare Advisory Partners first reported a position in GWPH in Q4 2018 and held it in 7 quarters. The position peaked at $31K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Wealthcare Advisory Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Wealthcare Advisory Partners sold 142 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $31K.
Wealthcare Advisory Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2018 and held it in 7 quarters.
Wealthcare Advisory Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $31K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.